Endothelial Dysfunction: Clinical Trials

7 trials for Endothelial Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 recruiting. 7 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Recruiting 7
Phase 13Recruiting 3

Follow Endothelial Dysfunction: new trials by email Literature Review of Endothelial Dysfunction trials Research Report on Endothelial Dysfunction

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men
Pitavastatin 1-4 mg daily, Rosuvastatin 20-40 mg daily - Erectile Dysfunction Due to Arterial Disease, Atheroscleroses
Phase 2RecruitingLomonosov Moscow State University Medical Research and Educational Center1502026-03-052026-03-16
TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD
TB-500, Placebo - Atherosclerotic Cardiovascular Diseases, Endothelial Dysfunction
Phase 1 / Phase 2RecruitingHudson Biotech802026-02-052026-11-12
Infusion of Prostacyclin vs Placebo for 72-hours in Mechanically Ventilated Patients With Acute Respiratory Failure
Iloprost, Isotonic saline - Acute Respiratory Failure, Endothelial Dysfunction
Phase 2RecruitingPär Johansson4502024-04-152025-08-22
Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
Dulaglutide, Placebo - Diabetes Mellitus, Type 1, Endothelial Dysfunction
Phase 2RecruitingAdventHealth Translational Research Institute472023-10-052026-10-15
Ischemic Conditioning to Promote Microvascular Resiliency in Frail Individuals
Ischemic Conditioning - Aging, Fragility
Phase 2RecruitingMedical College of Wisconsin602023-05-022025-09-23
Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia
Drug Lowering Cerebral Blood Flow (CBF) and Normoxia Sleep, Drug Lowering CBF and Intermittent Hypoxia Sleep, Placebo and Normoxia Sleep - Obstructive Sleep Apnea of Adult, Hypoxia, Brain
Phase 1 / Phase 2RecruitingUniversity of Calgary122023-01-012026-05-01
Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans
Galantamine, Placebo, TENS 7000 - Endothelial Dysfunction
Phase 1 / Phase 2RecruitingVanderbilt University Medical Center1602021-12-202026-05-18

Narrower conditions

Atherosclerosis (2)  ·  Aneurysm (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Artery Disease (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Erectile Dysfunction (1)  ·  Hypoxia, Brain (1)  ·  Inflammation (1)  ·  Motor Activity (1)  ·  Sleep Apnea Syndromes (1)  ·  Sleep Wake Disorders (1)  ·  Stroke (1)

Broader conditions

Vascular Diseases (4)  ·  Cardiovascular Diseases (3)  ·  Arterial Occlusive Diseases (2)  ·  Arteriosclerosis (2)  ·  Mental Disorders (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Apnea (1)  ·  Autoimmune Diseases (1)  ·  Behavior (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Coronary Disease (1)  ·  Diabetes Mellitus (1)  ·  Dyssomnias (1)

Interventions

Cerebrovascular Circulation (1)  ·  Core Binding Factors (1)  ·  Galantamine (1)  ·  Iloprost (1)  ·  Rosuvastatin Calcium (1)  ·  Sodium Chloride (1)  ·  Sugars (1)  ·  dulaglutide (1)  ·  pitavastatin (1)

Sponsors

AdventHealth Translational Research Institute (1)  ·  Hudson Biotech (1)  ·  Lomonosov Moscow State University Medical Research and Educational Center (1)  ·  Medical College of Wisconsin (1)  ·  Pär Johansson (1)  ·  University of Calgary (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (3)  ·  Canada (1)  ·  China (1)  ·  Denmark (1)  ·  Russia (1)

Top investigators

Cyndya Shibao, MD (1)  ·  Kaitlin Love, MD (1)  ·  Peter Soee-Jensen, MD (1)

NIH funding

K23DK131327 (1)